Effects of therapy with [(177)Lu-DOTA(0),Tyr(3)]octreotate on endocrine function

PURPOSE: Peptide receptor radionuclide therapy (PRRT) with radiolabelled somatostatin analogues is a novel therapy for patients with somatostatin receptor-positive tumours. We determined the effects of PRRT with [(177)Lu-DOTA(0),Tyr(3)]octreotate ((177)Lu-octreotate) on glucose homeostasis and the p...

Descripción completa

Detalles Bibliográficos
Autores principales: Teunissen, Jaap J. M., Krenning, Eric P., de Jong, Frank H., de Rijke, Yolanda B., Feelders, Richard A., van Aken, Maarten O., de Herder, Wouter W., Kwekkeboom, Dik J.
Formato: Texto
Lenguaje:English
Publicado: Springer-Verlag 2009
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2764054/
https://www.ncbi.nlm.nih.gov/pubmed/19471926
http://dx.doi.org/10.1007/s00259-009-1151-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2764054/
https://www.ncbi.nlm.nih.gov/pubmed/19471926
http://dx.doi.org/10.1007/s00259-009-1151-8

Ejemplares similares